| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
*
Naval Medical Research Institute, Bethesda, MD 20889;
Walter Reed Army Institute for Research, Rockville, MD 20850;
Henry M. Jackson Foundation for the Advancement of Military Medicine, U.S. Military HIV Research Program, Bethesda, MD 20889; and
§
Genetics Institute, Inc., Cambridge, MA 02140
We have assessed the functional effects of a panel of CTLA-4 mAbs on resting human CD4+ T cells. Our results demonstrate that some CTLA-4 mAbs can inhibit proliferative responses of resting CD4+ cells and cell cycle transition from G0 to G1. The inhibitory effects of CTLA-4 were evident within 4 h, at a time when cell surface CTLA-4 expression remained undetectable. Other CTLA-4 mAbs had no detectable inhibitory effects, indicating that binding of Ab to CTLA-4 alone is not sufficient to mediate down-regulation of T cell responses. Interestingly, while IL-2 production was shut off, inhibitory anti-CTLA-4 mAbs permitted induction and expression of the cell survival gene bcl-XL. Consistent with this observation, cells remained viable and apoptosis was not detected after CTLA-4 ligation.
This article has been cited by other articles:
|
|
 |
|
  S. G. Zheng, J. H. Wang, W. Stohl, K. S. Kim, J. D. Gray, and D. A. Horwitz TGF-beta Requires CTLA-4 Early after T Cell Activation to Induce FoxP3 and Generate Adaptive CD4+CD25+ Regulatory Cells J. Immunol., March 15, 2006; 176(6): 3321 - 3329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Homann, W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, and M. G. von Herrath Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity J. Virol., January 1, 2006; 80(1): 270 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Parry, J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson, and J. L. Riley CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms Mol. Cell. Biol., November 1, 2005; 25(21): 9543 - 9553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mukherjee, A. Ahmed, and D. Nandi CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A J. Leukoc. Biol., July 1, 2005; 78(1): 144 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. CARROLL, J. N. MILLS, J. M. MONTGOMERY, D. G. BAUSCH, P. J. BLAIR, J. P. BURANS, V. FELICES, A. GIANELLA, N. IIHOSHI, S. T. NICHOL, et al. HANTAVIRUS PULMONARY SYNDROME IN CENTRAL BOLIVIA: RELATIONSHIPS BETWEEN RESERVOIR HOSTS, HABITATS, AND VIRAL GENOTYPES Am J Trop Med Hyg, January 1, 2005; 72(1): 42 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Riley and C. H. June The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation Blood, January 1, 2005; 105(1): 13 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inobe and R. H. Schwartz CTLA-4 Engagement Acts as a Brake on CD4+ T Cell Proliferation and Cytokine Production but Is Not Required for Tuning T Cell Reactivity in Adaptive Tolerance J. Immunol., December 15, 2004; 173(12): 7239 - 7248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Stephens, R. S. McHugh, M. J. Whitters, D. A. Young, D. Luxenberg, B. M. Carreno, M. Collins, and E. M. Shevach Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells J. Immunol., October 15, 2004; 173(8): 5008 - 5020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Chemnitz, R. V. Parry, K. E. Nichols, C. H. June, and J. L. Riley SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation J. Immunol., July 15, 2004; 173(2): 945 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Yi, S. Hajialiasgar, and E. Chuang Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo Int. Immunol., April 1, 2004; 16(4): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pandiyan, D. Gartner, O. Soezeri, A. Radbruch, K. Schulze-Osthoff, and M. C. Brunner-Weinzierl CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function J. Exp. Med., March 15, 2004; 199(6): 831 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Siu, B. M. Carreno, and J. Madrenas TCR subunit specificity of CTLA-4-mediated signaling J. Leukoc. Biol., December 1, 2003; 74(6): 1102 - 1107. [Abstract] [Full Text]
|
|
|
|
|
|
B. Vanhove, G. Laflamme, F. Coulon, M. Mougin, P. Vusio, F. Haspot, J. Tiollier, and J.-P. Soulillou Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-{alpha}1-antitrypsin fusion antibody Blood, July 15, 2003; 102(2): 564 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Parry, C. A. Rumbley, L. H. Vandenberghe, C. H. June, and J. L. Riley CD28 and Inducible Costimulatory Protein Src Homology 2 Binding Domains Show Distinct Regulation of Phosphatidylinositol 3-Kinase, Bcl-xL, and IL-2 Expression in Primary Human CD4 T Lymphocytes J. Immunol., July 1, 2003; 171(1): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Steel and T. B. Nutman CTLA-4 in Filarial Infections: Implications for a Role in Diminished T Cell Reactivity J. Immunol., February 15, 2003; 170(4): 1930 - 1938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bennett, D. Luxenberg, V. Ling, I-M. Wang, K. Marquette, D. Lowe, N. Khan, G. Veldman, K. A. Jacobs, V. E. Valge-Archer, et al. Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses J. Immunol., January 15, 2003; 170(2): 711 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mukherjee, P. K. Maiti, and D. Nandi Role of CD80, CD86, and CTLA4 on mouse CD4+ T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin J. Leukoc. Biol., November 1, 2002; 72(5): 921 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Riley, M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. P. Gregson, C. H. June, and P. S. Linsley Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors PNAS, September 3, 2002; 99(18): 11790 - 11795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Darlington, M. L. Baroja, T. A. Chau, E. Siu, V. Ling, B. M. Carreno, and J. Madrenas Surface Cytotoxic T Lymphocyte-associated Antigen 4 Partitions Within Lipid Rafts and Relocates to the Immunological Synapse under Conditions of Inhibition of T Cell Activation J. Exp. Med., May 20, 2002; 195(10): 1337 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guntermann and D. R. Alexander CTLA-4 Suppresses Proximal TCR Signaling in Resting Human CD4+ T Cells by Inhibiting ZAP-70 Tyr319 Phosphorylation: A Potential Role for Tyrosine Phosphatases J. Immunol., May 1, 2002; 168(9): 4420 - 4429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Haspot, F. Villemain, G. Laflamme, F. Coulon, D. Olive, J. Tiollier, J.-P. Soulillou, and B. Vanhove Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses Blood, March 15, 2002; 99(6): 2228 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-N. Avice, M. Rubio, M. Sergerie, G. Delespesse, and M. Sarfati Role of CD47 in the Induction of Human Naive T Cell Anergy J. Immunol., September 1, 2001; 167(5): 2459 - 2468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Riley, P. J. Blair, J. T. Musser, R. Abe, K. Tezuka, T. Tsuji, and C. H. June ICOS Costimulation Requires IL-2 and Can Be Prevented by CTLA-4 Engagement J. Immunol., April 15, 2001; 166(8): 4943 - 4948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. da Rocha Dias and C. E. Rudd CTLA-4 blockade of antigen-induced cell death Blood, February 15, 2001; 97(4): 1134 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. M. Broeren, G. S. Gray, B. M. Carreno, and C. H. June Costimulation Light: Activation of CD4+ T Cells with CD80 or CD86 Rather Than Anti-CD28 Leads to a Th2 Cytokine Profile J. Immunol., December 15, 2000; 165(12): 6908 - 6914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yi, M. McNerney, and S. K. Datta Regulatory Defects in Cbl and Mitogen-Activated Protein Kinase (Extracellular Signal-Related Kinase) Pathways Cause Persistent Hyperexpression of CD40 Ligand in Human Lupus T Cells J. Immunol., December 1, 2000; 165(11): 6627 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iida, H. Ohno, C. Nakaseko, M. Sakuma, M. Takeda-Ezaki, H. Arase, E. Kominami, T. Fujisawa, and T. Saito Regulation of Cell Surface Expression of CTLA-4 by Secretion of CTLA-4-Containing Lysosomes Upon Activation of CD4+ T Cells J. Immunol., November 1, 2000; 165(9): 5062 - 5068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation J. Exp. Med., October 2, 2000; 192(7): 1027 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. McGaha and J. W. Murphy CTLA-4 Down-Regulates the Protective Anticryptococcal Cell-Mediated Immune Response Infect. Immun., August 1, 2000; 68(8): 4624 - 4630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Carreno, F. Bennett, T. A. Chau, V. Ling, D. Luxenberg, J. Jussif, M. L. Baroja, and J. Madrenas CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression J. Immunol., August 1, 2000; 165(3): 1352 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Griffin, D. K. Hong, P. O. Holman, K.-M. Lee, M. J. Whitters, S. M. O'Herrin, F. Fallarino, M. Collins, D. M. Segal, T. F. Gajewski, et al. Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152) J. Immunol., May 1, 2000; 164(9): 4433 - 4442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Baroja, D. Luxenberg, T. Chau, V. Ling, C. A. Strathdee, B. M. Carreno, and J. Madrenas The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation J. Immunol., January 1, 2000; 164(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Heinzel and R. A. Maier Jr. Interleukin-4-Independent Acceleration of Cutaneous Leishmaniasis in Susceptible BALB/c Mice following Treatment with Anti-CTLA4 Antibody Infect. Immun., December 1, 1999; 67(12): 6454 - 6460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nakaseko, S. Miyatake, T. Iida, S. Hara, R. Abe, H. Ohno, Y. Saito, and T. Saito Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) Engagement Delivers an Inhibitory Signal through the Membrane-proximal Region in the Absence of the Tyrosine Motif in the Cytoplasmic Tail J. Exp. Med., September 20, 1999; 190(6): 765 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Perrin, C. H. June, J. H. Maldonado, R. B. Ratts, and M. K. Racke Blockade of CD28 During In Vitro Activation of Encephalitogenic T Cells or After Disease Onset Ameliorates Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 1999; 163(3): 1704 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Chambers, M. S. Kuhns, and J. P. Allison Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+ T cell responses PNAS, July 20, 1999; 96(15): 8603 - 8608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Riley, K. Schlienger, P. J. Blair, B. Carreno, N. Craighead, D. Kim, R. G. Carroll, and C. H. June Modulation of Susceptibility to HIV-1 Infection by the Cytotoxic T Lymphocyte Antigen 4 Costimulatory Molecule J. Exp. Med., June 6, 1999; 191(11): 1987 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khattri, J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone Lymphoproliferative Disorder in CTLA-4 Knockout Mice Is Characterized by CD28-Regulated Activation of Th2 Responses J. Immunol., May 15, 1999; 162(10): 5784 - 5791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Brunner, C. A. Chambers, F. K.-M. Chan, J. Hanke, A. Winoto, and J. P. Allison CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation J. Immunol., May 15, 1999; 162(10): 5813 - 5820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saverino, C. Tenca, D. Zarcone, A. Merlo, A. M. Megiovanni, M. T. Valle, F. Manca, C. E. Grossi, and E. Ciccone CTLA-4 (CD152) Inhibits the Specific Lysis Mediated by Human Cytolytic T Lymphocytes in a Clonally Distributed Fashion J. Immunol., January 15, 1999; 162(2): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Alegre, H. Shiels, C. B. Thompson, and T. F. Gajewski Expression and Function of CTLA-4 in Th1 and Th2 Cells J. Immunol., October 1, 1998; 161(7): 3347 - 3356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schlienger, K. Uyemura, D. Jullien, P. A. Sieling, T. H. Rea, P. S. Linsley3, and R. L. Modlin B7-1, But Not CD28, Is Crucial for the Maintenance of the CD4+ T Cell Responses in Human Leprosy J. Immunol., September 1, 1998; 161(5): 2407 - 2413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Scheipers and H. Reiser Fas-independent death of activated CD4+ T lymphocytes induced by CTLA-4 crosslinking PNAS, August 18, 1998; 95(17): 10083 - 10088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Horspool, P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee Nucleic Acid Vaccine-Induced Immune Responses Require CD28 Costimulation and Are Regulated by CTLA4 J. Immunol., March 15, 1998; 160(6): 2706 - 2714. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
